Anti-LRRC15 Antibodies and Antibody-Drug Conjugates (ADCs)
Published in World Intellectual Property Organization (WIPO), 2026
Two related patent publications detailing isolated anti-LRRC15 antibodies and specific antibody-drug conjugates (ADCs) for the treatment of cancer.
Recommended citation: Bristol Myers Squibb (Co-inventor: Yuntao Zhang). (2026). "Anti-LRRC15 Antibodies and Antibody-Drug Conjugates." WIPO Patent Publication Nos. WO/2026/112469 and WO/2026/112472.
Download Paper | Download Slides | Download Bibtex
